Discover the complexities surrounding the FDA's role in regulating health products, particularly compounded medications and dietary supplements. Dr. Lori breaks down the differences between FDA-approved drugs and those that fall outside its approval process, emphasizing the agency’s lack of authority in regulating the safety and efficacy of many supplements and compounded drugs. With a focus on the growing influence of companies like Hims & Hers, the conversation highlights the tension between traditional pharmaceutical practices and the new wave of healthcare options that empower individuals to take charge of their own well-being.

This episode also tackles the issue of food labeling regulations, revealing how the FDA's minimal oversight can lead to misleading claims and confusion among consumers. With recent developments like the ban on certain food dyes, Dr. Lori critiques the FDA’s inconsistent enforcement of food and supplement regulations, raising questions about the agency’s relationship with large pharmaceutical companies and its true impact on public health.

We challenge all listeners to rethink the role of regulatory bodies in healthcare and advocate for more informed choices, transparency, and innovation in the pursuit of better health!

Id. d’épisode : 1000696117933

GUID : https://permalink.castos.com/podcast/29877/episode/1982059

Date de publication : 26/2/2025 à 04:23:41